Your search returned 158 results.

Results
	1.	Does prostate volume affect accurate grading of prostate biopsies? [electronic resource] by Thompson, Ian M Tangen, Catherine M Producer: 20061102 In: Nature clinical practice. Urology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Prostate cancer screening comes of age. [electronic resource] by Thompson, Ian M Tangen, Catherine M Producer: 20141215 In: Lancet (London, England) vol. 384 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Clinical trials: 'clinical integration': laudable, but challenging. [electronic resource] by Crawford, E David Tangen, Catherine M Producer: 20100305 In: Nature reviews. Urology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Prostate cancer--uncertainty and a way forward. [electronic resource] by Thompson, Ian M Tangen, Catherine M Producer: 20120726 In: The New England journal of medicine vol. 367 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	5α-Reductase Inhibitor Use in Patients With Prostate Cancer. [electronic resource] by Thompson, Ian M Tangen, Catherine M Kramer, Barnett Producer: 20200604 In: JAMA internal medicine vol. 179 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Is there a standard of care for pathologic stage T3 prostate cancer? [electronic resource] by Thompson, Ian M Tangen, Catherine M Klein, Eric A Producer: 20090709 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. [electronic resource] by Minasian, Lori M Tangen, Catherine M Wickerham, D Lawrence Producer: 20160104 In: Seminars in oncology vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9. [electronic resource] by Thompson, Ian M Lucia, M Scott Tangen, Catherine M Producer: 20070927 In: International journal of epidemiology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	More on Long-Term Effects of Finasteride on Prostate Cancer Mortality. Reply. [electronic resource] by Goodman, Phyllis J Tangen, Catherine M Thompson, Ian M Producer: 20190521 In: The New England journal of medicine vol. 380 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	The Prostate Cancer Prevention Trial and the future of chemoprevention. [electronic resource] by Thompson, Ian M Tangen, Catherine M Lucia, M Scott Producer: 20080424 In: BJU international vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma. [electronic resource] by Thompson, Ian M Ankerst, Donna P Tangen, Catherine M Producer: 20100928 In: Journal of the National Cancer Institute vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Survival in the prostate cancer prevention trial. [electronic resource] by Tangen, Catherine M Goodman, Phyllis J Thompson, Ian M Producer: 20131122 In: The New England journal of medicine vol. 369 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Prostate-specific antigen: a misused and maligned prostate cancer biomarker. [electronic resource] by Thompson, Ian M Tangen, Catherine M Kristal, Alan R Producer: 20081114 In: Journal of the National Cancer Institute vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Re: Long-term survival of participants in the Prostate Cancer Prevention Trial. [electronic resource] by Thompson, Ian M Tangen, Catherine M Goodman, Phyllis J Producer: 20141217 In: Asian journal of andrology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Robustifying Trial-Derived Optimal Treatment Rules for A Target Population. [electronic resource] by Zhao, Ying-Qi Zeng, Donglin Tangen, Catherine M LeBlanc, Michael L Publication details: Electronic journal of statistics 2019 In: Electronic journal of statistics vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning. [electronic resource] by Glass, Tracy R Tangen, Catherine M Crawford, E David Thompson, Ian Producer: 20030109 In: The Journal of urology vol. 169 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Biased hormonal therapy duration analysis makes results uninterpretable. [electronic resource] by Tangen, Catherine M Goldman, Bryan H Swanson, Gregory P Thompson, Ian M Producer: 20100105 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Phase III prostate cancer prevention trials: are the costs justified? [electronic resource] by Thompson, Ian M Tangen, Catherine M Klein, Eric A Lippman, Scott M Producer: 20051228 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials. [electronic resource] by Tangen, Catherine M Goodman, Phyllis J Crowley, John J Thompson, Ian M Producer: 20040217 In: The Journal of urology vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. [electronic resource] by Lerner, Seth P Tangen, Catherine M Sucharew, Heidi Wood, David Crawford, E David Producer: 20090701 In: Urologic oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 158 results.